Related Experiment Videos

Preoperative steroid-related complications in Japanese pediatric patients with ulcerative colitis

Keiichi Uchida1, Toshimitsu Araki, Yuji Toiyama

  • 1Second Department of Surgery, Mie University School of Medicine, Edobashi 2-174, Tsu, Mie, 514-8507, Japan.

Diseases of the Colon and Rectum
|November 12, 2005
PubMed

Insights

Pediatric ulcerative colitis patients experience more steroid complications at lower doses than adults. Early consideration of alternative therapies, like surgery, is crucial for improving quality of life.

Area of Science:

  • Gastroenterology
  • Pediatric Surgery
  • Pharmacology

Background:

  • Ulcerative colitis (UC) management in pediatric patients often involves steroid therapy.
  • Steroid therapy is associated with significant complications, particularly in younger patients.
  • Defining optimal steroid dosage limits and timing for alternative therapies is critical for pediatric UC.

Purpose of the Study:

  • To analyze major steroid-related complications in pediatric UC patients undergoing surgery.
  • To determine the threshold for steroid therapy complications in relation to dosage.
  • To inform decisions regarding the timing of alternative therapies, including surgery, for pediatric UC.

Main Methods:

  • Retrospective review of medical records for 28 pediatric and 57 adult UC patients who underwent proctocolectomy with ileal J-pouch-anal anastomosis.
  • Evaluation of the correlation between preoperative glucocorticoid dosage (mg/kg or mg/m2) and major steroid-related complications.
  • Comparison of surgical outcomes between pediatric and adult patient groups.

Main Results:

  • Pediatric patients exhibited higher rates of growth retardation, osteoporosis, glaucoma, and cataracts compared to adults.
  • Major steroid-related complications occurred at significantly lower cumulative steroid doses in pediatric patients.
  • Surgical procedures were comparable between pediatric and adult groups, but complications impacted long-term quality of life.

Conclusions:

  • Evidence-based guidelines for pediatric glucocorticoid dosing (per body weight or surface area) are needed.
  • Early consideration of alternative treatments, such as surgery, should be explored to enhance patient well-being and quality of life.
  • Optimizing steroid use and treatment pathways is essential for managing pediatric ulcerative colitis effectively.
Abstract

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...